Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP51591.RArpC1i2RvRC91cU-9PczOG35tozxcO2tTsuQwhM1eJdk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP51591.RArpC1i2RvRC91cU-9PczOG35tozxcO2tTsuQwhM1eJdk130_assertion type Assertion NP51591.RArpC1i2RvRC91cU-9PczOG35tozxcO2tTsuQwhM1eJdk130_head.
- NP51591.RArpC1i2RvRC91cU-9PczOG35tozxcO2tTsuQwhM1eJdk130_assertion description "[The response rates at the 3rd and 7th days after medication did not differ with either the drug group or the dopamine transporter polymorphism. Relatively low doses of risperidone and haloperidol exhibited similar efficacies, and dopamine transporter polymorphisms do not appear to play a major role in the action of antipsychotics on delirium.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP51591.RArpC1i2RvRC91cU-9PczOG35tozxcO2tTsuQwhM1eJdk130_provenance.
- NP51591.RArpC1i2RvRC91cU-9PczOG35tozxcO2tTsuQwhM1eJdk130_assertion evidence source_evidence_literature NP51591.RArpC1i2RvRC91cU-9PczOG35tozxcO2tTsuQwhM1eJdk130_provenance.
- NP51591.RArpC1i2RvRC91cU-9PczOG35tozxcO2tTsuQwhM1eJdk130_assertion SIO_000772 15823165 NP51591.RArpC1i2RvRC91cU-9PczOG35tozxcO2tTsuQwhM1eJdk130_provenance.
- NP51591.RArpC1i2RvRC91cU-9PczOG35tozxcO2tTsuQwhM1eJdk130_assertion wasDerivedFrom gad-20130706 NP51591.RArpC1i2RvRC91cU-9PczOG35tozxcO2tTsuQwhM1eJdk130_provenance.
- NP51591.RArpC1i2RvRC91cU-9PczOG35tozxcO2tTsuQwhM1eJdk130_assertion wasGeneratedBy ECO_0000203 NP51591.RArpC1i2RvRC91cU-9PczOG35tozxcO2tTsuQwhM1eJdk130_provenance.